IHT Wealth Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,800
| Closed | -$57.6K | – | 1013 |
|
|
2023
Q2 | $57.6K | Buy |
28,800
+2,000
| +7% | +$4K | ﹤0.01% | 947 |
|
|
2023
Q1 | $56.3K | Hold |
26,800
| – | – | ﹤0.01% | 927 |
|
|
2022
Q4 | $36.7K | Buy |
26,800
+4,800
| +22% | +$6.58K | ﹤0.01% | 887 |
|
|
2022
Q3 | $23K | Hold |
22,000
| – | – | ﹤0.01% | 855 |
|
|
2022
Q2 | $24K | Sell |
22,000
-2,000
| -8% | -$2.18K | ﹤0.01% | 719 |
|
|
2022
Q1 | $25K | Hold |
24,000
| – | – | ﹤0.01% | 756 |
|
|
2021
Q4 | $20K | Sell |
24,000
-9,200
| -28% | -$7.67K | ﹤0.01% | 799 |
|
|
2021
Q3 | $44K | Buy |
+33,200
| New | +$44K | ﹤0.01% | 790 |
|